Found: 12
Select item for more details and to access through your institution.
Evaluating the therapeutic efficacy of phytochemicals in ameliorating cytotoxic effects of amyloid beta.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, n. 21, p. 1, doi. 10.1002/alz.079471
- By:
- Publication type:
- Article
Development of a blood‐based biomarker signature for detection of cognitive impairment through a targeted metabolomics approach deciphering the association with depression.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2023, v. 19, p. 1, doi. 10.1002/alz.078702
- By:
- Publication type:
- Article
Cerebrospinal fluid levels of fatty acid binding protein 3 associate with brain amyloidosis in cognitively healthy individuals at risk of developing Alzheimer's disease.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2021, v. 17, p. 1, doi. 10.1002/alz.058583
- By:
- Publication type:
- Article
Cerebrospinal fluid fatty acid binding protein 3: A screening biomarker for preclinical Alzheimer's disease: Developing topics.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.047544
- By:
- Publication type:
- Article
Elevated levels of synaptic protein GAP‐43 associate with brain tauopathy, atrophy and cognition in Alzheimer's disease: Biomarkers (non‐neuroimaging) / Differential diagnosis.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.044098
- By:
- Publication type:
- Article
Neurofilament light chain in psychiatric and neurodegenerative disorders: A 'c‐reactive protein' for the brain?: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041347
- By:
- Publication type:
- Article
Neuroserpin, a crucial regulator for axogenesis, synaptic modelling and cell–cell interactions in the pathophysiology of neurological disease.
- Published in:
- Cellular & Molecular Life Sciences, 2022, v. 79, n. 3, p. 1, doi. 10.1007/s00018-022-04185-6
- By:
- Publication type:
- Article
Cerebrospinal fluid biomarkers for understanding multiple aspects of Alzheimer's disease pathogenesis.
- Published in:
- Cellular & Molecular Life Sciences, 2019, v. 76, n. 10, p. 1833, doi. 10.1007/s00018-019-03040-5
- By:
- Publication type:
- Article
Cerebrospinal fluid levels of fatty acid–binding protein 3 are associated with likelihood of amyloidopathy in cognitively healthy individuals.
- Published in:
- Alzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2022, v. 14, n. 1, p. 1, doi. 10.1002/dad2.12377
- By:
- Publication type:
- Article
Cerebrospinal Fluid Neurofilament Light Predicts Risk of Dementia Onset in Cognitively Healthy Individuals and Rate of Cognitive Decline in Mild Cognitive Impairment: A Prospective Longitudinal Study.
- Published in:
- Biomedicines, 2022, v. 10, n. 5, p. 1045, doi. 10.3390/biomedicines10051045
- By:
- Publication type:
- Article
Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's Disease.
- Published in:
- Aging & Disease, 2021, v. 12, n. 8, p. 1964, doi. 10.14336/AD.2021.0719
- By:
- Publication type:
- Article
A pilot study of the utility of cerebrospinal fluid neurofilament light chain in differentiating neurodegenerative from psychiatric disorders: A 'C-reactive protein' for psychiatrists and neurologists?
- Published in:
- Australian & New Zealand Journal of Psychiatry, 2020, v. 54, n. 1, p. 57, doi. 10.1177/0004867419857811
- By:
- Publication type:
- Article